Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity
<strong>Objectives</strong> To evaluate the relationship between radiographic progression and disease activity in subjects with PsA treated with adalimumab (ADA) or placebo (PBO) and the impact of concomitant MTX. <br/><br/> <strong>Methods</strong> This was a pos...
Main Authors: | Landewé, R, Ritchlin, C, Aletaha, D, Zhang, Y, Ganz, F, Hojnik, M, Coates, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2019
|
Similar Items
-
Radiographic efficacy of adalimumab in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use and clinical response: subanalysis of adept
by: Choy, E, et al.
Published: (2007) -
Adalimumab in treatment of psoriatic arthritis
by: V. V. Badokin
Published: (2008-08-01) -
Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept
by: Kavanaugh, A, et al.
Published: (2005) -
THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01) -
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled tria
by: Ritchlin, CT, et al.
Published: (2023)